Evogene (EVGN) Income from Discontinued Operations (2024 - 2026)

Evogene has disclosed Income from Discontinued Operations across 3 years of filings, most recently posting -$176000.0 for Q2 2026.

• In Q2 2026, Income from Discontinued Operations rose 89.47% year-over-year to -$176000.0; the TTM figure through Jun 2026 stood at $7.7 million (up 248.54% YoY), while the FY2025 annual figure was $3.5 million, up 207.01% from the prior year.
• Income from Discontinued Operations came in at -$176000.0 for Q2 2026 at Evogene, down from $14000.0 in the prior quarter.
• In the past five years, Income from Discontinued Operations ranged from a high of $7.9 million in Q3 2025 to a low of -$1.7 million in Q2 2025.
• Average Income from Discontinued Operations over 3 years is $316500.0, with a median of -$582000.0 recorded in 2024.
• Year-over-year, Income from Discontinued Operations surged 638.82% in 2025 and jumped 89.47% in 2026.
• Over 3 years, Income from Discontinued Operations stood at -$988000.0 in 2024, then surged by 98.38% to -$16000.0 in 2025, then slumped by 1000.0% to -$176000.0 in 2026.
• Per Business Quant data, the three most recent Income from Discontinued Operations figures were -$176000.0 in Q2 2026, $14000.0 in Q1 2026, and -$16000.0 in Q4 2025.